BR9709154A - Utilização de um inibidor da atividade do ácido retinóico em uma composição cosmética ou para a preparação de uma composição farmacêutica - Google Patents

Utilização de um inibidor da atividade do ácido retinóico em uma composição cosmética ou para a preparação de uma composição farmacêutica

Info

Publication number
BR9709154A
BR9709154A BR9709154A BR9709154A BR9709154A BR 9709154 A BR9709154 A BR 9709154A BR 9709154 A BR9709154 A BR 9709154A BR 9709154 A BR9709154 A BR 9709154A BR 9709154 A BR9709154 A BR 9709154A
Authority
BR
Brazil
Prior art keywords
inhibitor
preparation
retinoic acid
acid activity
pharmaceutical composition
Prior art date
Application number
BR9709154A
Other languages
English (en)
Inventor
Michel Demarchez
Patricia Rossio
Andre Jomard
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Publication of BR9709154A publication Critical patent/BR9709154A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
BR9709154A 1996-09-20 1997-09-17 Utilização de um inibidor da atividade do ácido retinóico em uma composição cosmética ou para a preparação de uma composição farmacêutica BR9709154A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611511A FR2753627B1 (fr) 1996-09-20 1996-09-20 Utilisation des inhibiteurs de l'activite de l'acide retinoique pour favoriser la cicatrisation
PCT/FR1997/001641 WO1998011886A1 (fr) 1996-09-20 1997-09-17 Utilisation des inhibiteurs de l'activite de l'acide retinoique pour favoriser la cicatrisation

Publications (1)

Publication Number Publication Date
BR9709154A true BR9709154A (pt) 1999-08-03

Family

ID=9495934

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709154A BR9709154A (pt) 1996-09-20 1997-09-17 Utilização de um inibidor da atividade do ácido retinóico em uma composição cosmética ou para a preparação de uma composição farmacêutica

Country Status (14)

Country Link
US (1) US5973007A (pt)
EP (1) EP0874626B1 (pt)
JP (1) JPH11500464A (pt)
AR (1) AR008638A1 (pt)
AT (1) ATE285761T1 (pt)
AU (1) AU707390B2 (pt)
BR (1) BR9709154A (pt)
CA (1) CA2236309A1 (pt)
DE (1) DE69732092D1 (pt)
FR (1) FR2753627B1 (pt)
MX (1) MX9803995A (pt)
NZ (1) NZ330401A (pt)
WO (1) WO1998011886A1 (pt)
ZA (1) ZA978400B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
WO2002022113A2 (en) 2000-09-13 2002-03-21 Bristol-Myers Squibb Company Retinoic acid receptor antagonists as promoters of angiogenesis
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
US7105566B2 (en) * 2002-10-22 2006-09-12 Allergan, Inc. Methods of treatment during vascular procedures
FR2847167A1 (fr) * 2002-11-15 2004-05-21 Galderma Res & Dev UTILISATION D'UN ANTAGONISTE DES RECEPTEURS RARs POUR POTENTIALISER L'ACTION DU TGFb
AU2003302070A1 (en) * 2002-11-15 2004-06-15 Galderma Research And Development, S.N.C. USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta
WO2005115403A2 (en) * 2004-05-26 2005-12-08 Cedars-Sinai Medical Center Induction of innate immunity by vitamin d3 and its analogs
US20070049579A1 (en) * 2005-03-04 2007-03-01 Ryozo Nagai Medicament having neovascularization promoting action
EP1764411B1 (en) 2005-07-26 2013-10-02 Kao Corporation Alkaline xylanase
US20080027031A1 (en) * 2006-03-08 2008-01-31 Kinemed, Inc. Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
US11793867B2 (en) 2017-12-18 2023-10-24 Biontech Us Inc. Neoantigens and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237003A (en) * 1990-02-12 1992-12-23 Squibb & Sons Inc A bandage comprising a retinoid in or on the skin contacting surface
FR2663850B1 (fr) * 1990-07-02 1994-01-14 Gird Galderma Composition pharmaceutique ou cosmetique contenant en association un retinouide et un sterol.
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
EP0638071B1 (en) * 1992-12-28 1997-04-09 Eisai Co., Ltd. Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)
FR2713640B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
CA2138000A1 (en) * 1994-01-03 1995-07-04 John E. Starrett, Jr. Retinoid-like compounds
US5807900A (en) * 1995-03-31 1998-09-15 Hoffmann-La Roche, Inc. Method for identifying compounds having increased activity for the repair of skin photodamage
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
US5808124A (en) * 1996-06-21 1998-09-15 Allergan O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Also Published As

Publication number Publication date
EP0874626B1 (fr) 2004-12-29
EP0874626A1 (fr) 1998-11-04
AR008638A1 (es) 2000-02-09
JPH11500464A (ja) 1999-01-12
ATE285761T1 (de) 2005-01-15
AU707390B2 (en) 1999-07-08
MX9803995A (es) 1998-09-30
AU4306197A (en) 1998-04-14
CA2236309A1 (fr) 1998-03-26
FR2753627A1 (fr) 1998-03-27
ZA978400B (en) 1998-03-26
DE69732092D1 (de) 2005-02-03
NZ330401A (en) 1999-05-28
WO1998011886A1 (fr) 1998-03-26
FR2753627B1 (fr) 2003-02-21
US5973007A (en) 1999-10-26

Similar Documents

Publication Publication Date Title
DE69033731T2 (de) Depigmentierendes pharmazeutisches oder kosmetisches mittel mit kaffeinsäure
BR9706311A (pt) Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética
HUP9903687A3 (en) Arylsulfonylamino carboxylic and hidroxamic acid derivatives and pharmaceutical compositions with metalloproteinase inhibitory activity containing them
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
HU9601161D0 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
BR9709154A (pt) Utilização de um inibidor da atividade do ácido retinóico em uma composição cosmética ou para a preparação de uma composição farmacêutica
HUP0100152A3 (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity, pharmaceutical compositions containing them and their use
HUP0001269A3 (en) 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof
BR9810121A (pt) Utilização do acido petroselìnico nativo ou esterificado
ZA978660B (en) Skin care compositions containing combinations of compounds for mimicking the effect on skin of retinoic acid
BR9800728A (pt) Composição para tratamento de cabelo e usos da composição e de ingredientes como precursores de ácido graxo de lipídeo integral de cabelo em uma composição para tratamento de cabelo
BR9711421A (pt) Composi-Æo para o cuidado da pele processos cosm-ticos para condicionar a pele e para imitar o efeito sobre a pele de cido retinÄico
BR9706902A (pt) Uso de pelo menos um inibidor da atividade do ácido retinóico e composição
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
PT842927E (pt) 3-AMIDO-CROMANILSULFONIL(TIO)-UREIAS PROCESSOS PARA A SUA PREPARACAO SUA UTILIZACAO E COMPOSICOES FARMACêUTICAS QUE AS CONTEM
BR9702608A (pt) Composição cosmética dermatológica higiênica e/ou framacêutica sem transferência utilização da associação entre um composto volátil e um polímero processo para limitar diminuir e/ou empedir a transferência
FR2723316B1 (fr) Compositions et preparations depigmentantes de la peau, a usages pharmaceutiques ou cosmetiques
BR9702604A (pt) Composição cosmética dermatológica higiênica e/ou farmacêutica composição cosmética demartológica higiênica e/ou farmacêutica sem transferência utilizando da associação entre um composto volátil e um composto pastoso e processo para limitar diminuir e/ou elimar a transferência
BR9800753B1 (pt) composição cosmética e/ou dermatológica e uso de uma composição.
BR9711315A (pt) Composi-Æo farmac-utica contendo cidos 4-oxobutanÄicos
IL111152A0 (en) Retinoic acid esters, their preparation and pharmaceutical or cosmetic compositions containing them
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
PT1017388E (pt) Composicao farmaceutica contendo ibuprofeno e domperidona para o tratamento de enxaqueca
AU6625698A (en) Novel salicylic acid derivatives and their use in cosmetic or dermatological compositions

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.